Sensitivity of point-of-care testing C reactive protein and procalcitonin to diagnose urinary tract infections in Dutch nursing homes: PROGRESS study protocol

Introduction Suspected urinary tract infection (UTI) ranks among the most common reasons for antibiotic use in nursing homes. However, diagnosing UTI in this setting is challenging because UTI often presents with non-specific symptomatology. Moreover asymptomatic bacteriuria is common in elderly, wh...

Full description

Saved in:
Bibliographic Details
Main Authors: Sacha D Kuil, Soemeja Hidad, Johan C Fischer, Janneke Harting, Cees MPM Hertogh, Jan M Prins, Frank van Leth, Menno D de Jong, Caroline Schneeberger
Format: Article
Language:English
Published: BMJ Publishing Group 2019-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/9/8/e031269.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846151953743085568
author Sacha D Kuil
Soemeja Hidad
Johan C Fischer
Janneke Harting
Cees MPM Hertogh
Jan M Prins
Frank van Leth
Menno D de Jong
Caroline Schneeberger
author_facet Sacha D Kuil
Soemeja Hidad
Johan C Fischer
Janneke Harting
Cees MPM Hertogh
Jan M Prins
Frank van Leth
Menno D de Jong
Caroline Schneeberger
author_sort Sacha D Kuil
collection DOAJ
description Introduction Suspected urinary tract infection (UTI) ranks among the most common reasons for antibiotic use in nursing homes. However, diagnosing UTI in this setting is challenging because UTI often presents with non-specific symptomatology. Moreover asymptomatic bacteriuria is common in elderly, which complicates attribution of causality to detection of bacteria in urine. These diagnostic challenges contribute to overuse of antibiotics and emergence of antimicrobial resistance in nursing homes. Given the diagnostic challenges, there is a need for point-of-care (POC) diagnostic tests to support clinical rules for diagnosing UTI. Procalcitonin (PCT) and C reactive protein (CRP) are inflammatory blood markers that have been proven useful to support diagnosis and monitoring of (bacterial) respiratory tract infections and sepsis. While limited studies suggest their usefulness in supporting UTI diagnosis, their utility has not been studied in elderly populations for this purpose.Methods and analysis In a 24-month matched prospective study, ‘PROGRESS’ will assess and compare the sensitivity of rapid POC measurements of blood CRP and PCT levels to support clinical rules for diagnosing UTI in nursing home residents. The primary outcome measure is sensitivity of the POC tests to identify patients with true UTI based on the predefined definition, as derived from receiver operating curves.Ethics and dissemination This study will be conducted in accordance with Good Clinical Practice guidelines and the principles of the Declaration of Helsinki. The study protocol is approved by the Medical Ethical Committee of Amsterdam UMC location VUmc with reference number 2017.350 and National Central Committee on Research involving Human Subjects with reference number NL62067.029.17.Trial registration number NTR6467.
format Article
id doaj-art-0e4cfce9b36b4dfdb91a618355b85f9f
institution Kabale University
issn 2044-6055
language English
publishDate 2019-08-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-0e4cfce9b36b4dfdb91a618355b85f9f2024-11-27T02:45:10ZengBMJ Publishing GroupBMJ Open2044-60552019-08-019810.1136/bmjopen-2019-031269Sensitivity of point-of-care testing C reactive protein and procalcitonin to diagnose urinary tract infections in Dutch nursing homes: PROGRESS study protocolSacha D Kuil0Soemeja Hidad1Johan C Fischer2Janneke Harting3Cees MPM Hertogh4Jan M Prins5Frank van Leth6Menno D de Jong7Caroline Schneeberger81 Medical Microbiology, Amsterdam UMC University of Amsterdam, Amsterdam, The Netherlands1 Medical Microbiology, Amsterdam UMC University of Amsterdam, Amsterdam, The Netherlands2 Clinical Chemistry, Amsterdam UMC University of Amsterdam, Amsterdam, The NetherlandsPublic and Occupational Health, Amsterdam UMC, Location AMC, Amsterdam Public Health research institute, Amsterdam, The Netherlands4 General Practice and Elderly Care Medicine, Amsterdam UMC Vrije Universiteit Amsterdam, Amsterdam, The Netherlands5 Internal Medicine, Amsterdam UMC University of Amsterdam, Amsterdam, The Netherlands6 Global Health, Amsterdam Institute for Global Health and Development, Amsterdam, The NetherlandsInfectious Diseases, Amsterdam Institute for Infection and Immunity, Amsterdam, The NetherlandsDepartment of Microbiology, Amsterdam UMC-Locatie AMC, Amsterdam, The NetherlandsIntroduction Suspected urinary tract infection (UTI) ranks among the most common reasons for antibiotic use in nursing homes. However, diagnosing UTI in this setting is challenging because UTI often presents with non-specific symptomatology. Moreover asymptomatic bacteriuria is common in elderly, which complicates attribution of causality to detection of bacteria in urine. These diagnostic challenges contribute to overuse of antibiotics and emergence of antimicrobial resistance in nursing homes. Given the diagnostic challenges, there is a need for point-of-care (POC) diagnostic tests to support clinical rules for diagnosing UTI. Procalcitonin (PCT) and C reactive protein (CRP) are inflammatory blood markers that have been proven useful to support diagnosis and monitoring of (bacterial) respiratory tract infections and sepsis. While limited studies suggest their usefulness in supporting UTI diagnosis, their utility has not been studied in elderly populations for this purpose.Methods and analysis In a 24-month matched prospective study, ‘PROGRESS’ will assess and compare the sensitivity of rapid POC measurements of blood CRP and PCT levels to support clinical rules for diagnosing UTI in nursing home residents. The primary outcome measure is sensitivity of the POC tests to identify patients with true UTI based on the predefined definition, as derived from receiver operating curves.Ethics and dissemination This study will be conducted in accordance with Good Clinical Practice guidelines and the principles of the Declaration of Helsinki. The study protocol is approved by the Medical Ethical Committee of Amsterdam UMC location VUmc with reference number 2017.350 and National Central Committee on Research involving Human Subjects with reference number NL62067.029.17.Trial registration number NTR6467.https://bmjopen.bmj.com/content/9/8/e031269.full
spellingShingle Sacha D Kuil
Soemeja Hidad
Johan C Fischer
Janneke Harting
Cees MPM Hertogh
Jan M Prins
Frank van Leth
Menno D de Jong
Caroline Schneeberger
Sensitivity of point-of-care testing C reactive protein and procalcitonin to diagnose urinary tract infections in Dutch nursing homes: PROGRESS study protocol
BMJ Open
title Sensitivity of point-of-care testing C reactive protein and procalcitonin to diagnose urinary tract infections in Dutch nursing homes: PROGRESS study protocol
title_full Sensitivity of point-of-care testing C reactive protein and procalcitonin to diagnose urinary tract infections in Dutch nursing homes: PROGRESS study protocol
title_fullStr Sensitivity of point-of-care testing C reactive protein and procalcitonin to diagnose urinary tract infections in Dutch nursing homes: PROGRESS study protocol
title_full_unstemmed Sensitivity of point-of-care testing C reactive protein and procalcitonin to diagnose urinary tract infections in Dutch nursing homes: PROGRESS study protocol
title_short Sensitivity of point-of-care testing C reactive protein and procalcitonin to diagnose urinary tract infections in Dutch nursing homes: PROGRESS study protocol
title_sort sensitivity of point of care testing c reactive protein and procalcitonin to diagnose urinary tract infections in dutch nursing homes progress study protocol
url https://bmjopen.bmj.com/content/9/8/e031269.full
work_keys_str_mv AT sachadkuil sensitivityofpointofcaretestingcreactiveproteinandprocalcitonintodiagnoseurinarytractinfectionsindutchnursinghomesprogressstudyprotocol
AT soemejahidad sensitivityofpointofcaretestingcreactiveproteinandprocalcitonintodiagnoseurinarytractinfectionsindutchnursinghomesprogressstudyprotocol
AT johancfischer sensitivityofpointofcaretestingcreactiveproteinandprocalcitonintodiagnoseurinarytractinfectionsindutchnursinghomesprogressstudyprotocol
AT jannekeharting sensitivityofpointofcaretestingcreactiveproteinandprocalcitonintodiagnoseurinarytractinfectionsindutchnursinghomesprogressstudyprotocol
AT ceesmpmhertogh sensitivityofpointofcaretestingcreactiveproteinandprocalcitonintodiagnoseurinarytractinfectionsindutchnursinghomesprogressstudyprotocol
AT janmprins sensitivityofpointofcaretestingcreactiveproteinandprocalcitonintodiagnoseurinarytractinfectionsindutchnursinghomesprogressstudyprotocol
AT frankvanleth sensitivityofpointofcaretestingcreactiveproteinandprocalcitonintodiagnoseurinarytractinfectionsindutchnursinghomesprogressstudyprotocol
AT mennoddejong sensitivityofpointofcaretestingcreactiveproteinandprocalcitonintodiagnoseurinarytractinfectionsindutchnursinghomesprogressstudyprotocol
AT carolineschneeberger sensitivityofpointofcaretestingcreactiveproteinandprocalcitonintodiagnoseurinarytractinfectionsindutchnursinghomesprogressstudyprotocol